Total Reports
5
Low report volume
Horse /
Breed profile · FDA CVM July 2026 extract
Selle Français adverse-event record
Adverse-event filings for Selle Français (Horse) in the FDA Center for Veterinary Medicine openFDA extract. Browse horse breeds, reactions, and outcomes below.
- #508 of 510
- by report volume (all breeds)
- 5
- FDA CVM reports on file
- 0.0%
- death-coded share of reports
- 2
- Colic - top reaction
How the 5 reports break down
By recorded gender -- every report on file for Selle Français, no filtering.
Annual report volume
Data updated September 2026
The verdict
According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Selle Français ranks #490 of 510 by total reports (5). Death-coded-share rank requires at least 50 reports. National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).
- 93,675
- Retriever - Labrador reports (#1)
- 99.0%
- Atlantic Salmon (Salmo salar) death share (#1)
- #490
- This breed, reports of 510
Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.
Release-over-release change
What changed in the latest FDA data snapshot
PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Selle Français has 5 reports now versus 5 in that prior snapshot: 0 the same number of (0.0%).
- Report change
- +0
- Death-coded reports
- +0
- Death-coded share
- +0.0 pts
This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.
Subscribe to Selle Français changesDeaths Reported
0
of 5 reports
Death-coded share of reports
0.0%
0.0% death-coded
Avg Age at Report
14.7 yr
no age data
Death-Coded Outcome Share
Selle Français death-coded reports 0.0%
Cross-breed median
0.0% of 5 selle français reports involved a death outcome.
How to read this number
Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.
Top Reported Reactions
Colic 2
Injection site swelling 2
Malaise 1
Fever 1
Faecal impaction 1
Most Referenced Drugs
Pentosan Polysulfate Sodium 3
Fenbendazol Oral Paste 1
Pyrantel Pamoate (Pyrantel Embonate) 1
Clostridium Tetani Seed Lot #18 H-1 Massachusetts Strain;Eastern Equine Encephal 1
Flu/Rhino 1
Outcome Breakdown
Recovered/Normal
4 (80.0%)
Ongoing
1 (20.0%)
Gender Distribution
Male 4 (80.0%)
Female 1 (20.0%)
Reports by Year
| Year | Reports | Trend |
|---|---|---|
| 2020 | 1 | |
| 2025 | 4 | |
Selle Français: low death-coded share in the FDA CVM extract
Signature read: 5 reports place Selle Français in the lower third of breed filing volume (#508 of 510). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Selle Français sits at #508 of 510 by report volume among all breeds and #54 of 55 among horse breeds, with 5 reports and 0 (0.0%) death-coded. Mean age at report: 14.7 years.
Top reported signs: Colic (2), Injection site swelling (2), Malaise (1). Most-referenced drug: Pentosan Polysulfate Sodium (3 reports), followed by Fenbendazol Oral Paste (1) and Pyrantel Pamoate (Pyrantel Embonate) (1).
Outcome coding on 5 status-recorded reports is dominated by Recovered/Normal (80.0%). Annual submissions ranged 1-2,025 across 2 years on file.
Horse Breeds With a Similar Report Volume
Showing 6 of 54 horse breeds in our dataset, ranked by closest report volume.
What to do with this horse
- Read how death-coded share differs from a mortality rate before drawing conclusions. Breed-specific risks guide
- Browse every horse breed we track for comparison. All horse breeds
A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.
Frequently Asked Questions
How many FDA adverse event reports involve Selle Français? ▼
There are 5 adverse event reports involving Selle Français in the FDA database, of which 0 were death-coded (0.0% of those reports). That is a share of REPORTED events, not a mortality rate for the breed: adverse events reach the FDA when something goes wrong, so the denominator is reports, never the population of animals. According to the same FDA CVM extract, Selle Français ranks #508 of 510 by report volume among all breeds PlainBreed indexes (#54 of 55 among horse breeds).
Where does Selle Français sit among other breeds in PlainBreed's corpus? ▼
According to FDA CVM report volume, Selle Français is #508 of 510 breeds indexed on PlainBreed (same ordering as the most-reported-breeds ranking). Inside Horse, it is #54 of 55. It has fewer than 50 reports, so it is outside the death-rate ranking cohort (≥50 reports). These are placement ranks in the reporting corpus, not clinical risk scores.
What are the most common adverse reactions reported for Selle Français? ▼
The most commonly reported adverse reactions for Selle Français are Colic (2 reports), Injection site swelling (2 reports), Malaise (1 reports), Fever (1 reports), Faecal impaction (1 reports).
What drugs are most frequently associated with Selle Français adverse events? ▼
The drugs most frequently referenced in Selle Français adverse event reports are Pentosan Polysulfate Sodium (3 reports), Fenbendazol Oral Paste (1 reports), Pyrantel Pamoate (Pyrantel Embonate) (1 reports), Clostridium Tetani Seed Lot #18 H-1 Massachusetts Strain;Eastern Equine Encephal (1 reports), Flu/Rhino (1 reports).
What is the average age of Selle Français in adverse event reports? ▼
The average age of Selle Français at the time of adverse event reports is 14.7 years.
Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how the death-coded share and rankings are computed, or read breed-specific reporting patterns and FDA CVM reporting.
Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025
openFDA Animal & Veterinary Adverse Events (FDA CVM) for Selle Français (Horse), extract as of July 2026 extract. 5 reports · 0 death-coded (0.0% of reports, not a mortality rate) · #508 of 510 by volume.
Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →